Product Pipeline

I). Bio-similar Therapeutic Molecules

ARAHC has a range of Mammalian and Bacterial derived Recombinant Monoclonal Antibodies (Mab`s) and Proteins through the State-of-art of High Cell Density Fed Batch Culture System. The core strength of ARA`s Research team is in the designing and developing therapeutic molecules for human therapy.



II). Novel Therapeutic Molecules

ARAHC has also developed and working on the range of Novel Recombinant protein molecules for the treatment of cancer and rheumatoid arthritis . These products are at different stages of development .